Precision BioSciences Announces Board and Executive Changes
Ticker: DTIL · Form: 8-K · Filed: Sep 2, 2025 · CIK: 1357874
| Field | Detail |
|---|---|
| Company | Precision Biosciences Inc (DTIL) |
| Form Type | 8-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.000005 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
Board shakeup and comp changes at Precision BioSciences, effective Aug 26.
AI Summary
Precision BioSciences, Inc. announced on August 26, 2025, changes in its board and executive compensation. The filing details the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for key executives. These changes are effective as of August 26, 2025.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategy and execution.
Key Numbers
- 001-38841 — SEC File Number (Identifies the company's filing history with the SEC.)
- 20-4206017 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Precision BioSciences, Inc. (company) — Registrant
- August 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Durham, North Carolina (location) — Principal Executive Offices
FAQ
What specific roles have seen departures or appointments?
The filing indicates the departure of certain officers and directors, the election of new directors, and changes to compensatory arrangements for certain officers, but does not specify individual names or roles in this summary.
When were these changes effective?
The earliest event reported is dated August 26, 2025, and the date as of change is also August 26, 2025.
What is the company's principal executive office location?
The principal executive offices are located at 302 East Pettigrew St. Suite A-100, Durham, North Carolina 27701.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the SIC code for Precision BioSciences, Inc.?
The Standard Industrial Classification (SIC) code is 2836 for Biological Products (No Diagnostic Substances).
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 13.6 · Accepted 2025-09-02 07:15:42
Key Financial Figures
- $0.000005 — ich registered Common Stock, par value $0.000005 per share DTIL The Nasdaq Capital Marke
Filing Documents
- dtil-20250826.htm (8-K) — 24KB
- 0001357874-25-000005.txt ( ) — 139KB
- dtil-20250826.xsd (EX-101.SCH) — 2KB
- dtil-20250826_lab.xml (EX-101.LAB) — 22KB
- dtil-20250826_pre.xml (EX-101.PRE) — 13KB
- dtil-20250826_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRECISION BIOSCIENCES, INC. Date: September 2, 2025 By: /s/ Dario Scimeca Dario Scimeca General Counsel